cognitive cybersecurity intelligence
The patent for Insmed Inc.’s drug, ARIKAYCE KIT, is set to expire on April 8, 2024. The drug, which is marketed by Insmed and included in one NDA, is available from a single supplier.
Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.
Threat actors associated with Qilin and Warlock ransomware operations have been observed using the bring your own vulnerable driver (BYOVD) technique to silence security tools running on compromised hosts, according
A high-severity security bypass vulnerability in Anthropic’s Claude Code AI coding agent allows malicious actors to silently evade user-configured deny rules through a simple command-padding
Cybercriminals are launching a sophisticated new wave of attacks using fake Microsoft Teams domains. According to recent threat intelligence shared by SEAL Org, hackers are actively
Explore how centralizing dental credentialing and directories reduces fragmentation, risk and costs.
